In vivo and in vitro attenuation of naloxone-precipitated experimental opioid withdrawal syndrome by insulin and selective KATP channel modulator

Psychopharmacology

Volumn 232, Issue 2, 2015, Pages 465-475

  Singh, Prabhat ^a   Sharma, Bhupesh ^b,c   Gupta, Surbhi ^a   Sharma, B M ^b  

^a Neuropharmacology Lab Department of Pharmacology School of Pharmacy   (India)

^b BHARAT INSTITUTE OF TECHNOLOGY   (India)

^c Dilshad Garden   (India)

Author keywords

Calcium; Circling; Forepawlicking; Glucose; Glutathione; Jumping; Malondialdehyde; Morphine; Nitrite nitrate

Indexed keywords

ADENOSINE TRIPHOSPHATE SENSITIVE POTASSIUM CHANNEL; CALCIUM ION; GLICLAZIDE; GLUCOSE; GLUTATHIONE; INSULIN; MALONALDEHYDE; MORPHINE; NALOXONE; NITRATE; NITRITE; OPIATE; POTASSIUM CHANNEL AFFECTING AGENT; SELECTIVE ADENOSINE TRIPHOSPHATE SENSITIVE POTASSIUM CHANNEL MODULATOR; UNCLASSIFIED DRUG; NARCOTIC AGENT; NARCOTIC ANALGESIC AGENT; NARCOTIC ANTAGONIST;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BEHAVIOR CHANGE; BIOCHEMICAL COMPOSITION; BRAIN LEVEL; CONTROLLED STUDY; DISEASE PREDISPOSITION; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE HOMEOSTASIS; ILEUM; IN VITRO STUDY; IN VIVO STUDY; JUMPING; LICKING; MALE; MOUSE; NONHUMAN; OPIATE ADDICTION; PRIORITY JOURNAL; RAT; REARING; SNEEZING; TREMOR; WET DOG SHAKES; WITHDRAWAL SYNDROME; ANIMAL; ANTAGONISTS AND INHIBITORS; DRUG EFFECTS; DRUG INTERACTION; METABOLISM; MORPHINE DEPENDENCE; SUBSTANCE WITHDRAWAL SYNDROME;

ANALGESICS, OPIOID; ANIMALS; BEHAVIOR, ANIMAL; DRUG INTERACTIONS; IN VITRO TECHNIQUES; INSULIN; KATP CHANNELS; MALE; MICE; MORPHINE; MORPHINE DEPENDENCE; NALOXONE; NARCOTIC ANTAGONISTS; NARCOTICS; RATS; SUBSTANCE WITHDRAWAL SYNDROME;

EID: 84922271572     PISSN: 00333158     EISSN: 14322072     Source Type: Journal    
DOI: 10.1007/s00213-014-3680-5     Document Type: Article

References (85)

1. Abdel-Zaher AO, Abdel-Rahman MS, Elwasei FM (2011) Protective effect of Nigella sativa oil against tramadol-induced tolerance and dependence in mice: role of nitric oxide and oxidative stress. Neurotoxicology 32:725-733
2. Abouazra HA, Sharif SI (2001) Hyperglycaemia: a morphine-like effect produced by naloxone. Clin Exp Pharmacol Physiol 28:300-305
3. Alp H, Varol S, Celik MM, Altas M, Evliyaoglu O, Tokgoz O, Tanriverdi MH, Uzar E (2012) Protective effects of beta glucan and gliclazide on brain tissue and sciatic nerve of diabetic rats induced by streptozosin. Exp Diabetes Res. doi:10.1155/2012/230342, PMID: 22291696
4. Altan VM, Oztürk Y, Yildizoʇlu-Ari N, Nebigil C, Lafçi D, Ozçelikay AT (1989) Insulin action on different smooth muscle preparations. Gen Pharmacol 20:529-535
5. Bi Y, Meng-yin C, Liang H, Sun WP, Chen X, Zhu YH, He XY, Yu QQ, Li M, Weng JP (2009) Effect of early insulin therapy on nuclear factor-kappaB inflammatory pathway in liver of diabetic rat. Zhonghua Nei Ke Za Zhi 48:17-22
6. Biala G, Betancur C, Mansuy IM, Giros B (2005) The reinforcing effects of chronic D-amphetamine and morphine are impaired in a line of memory-deficient mice overexpressing calcineurin. Eur J Neurosci 21:3089-3096
7. Biddinger SB, Kahn CR (2006) From mice to men: insights into the insulin resistance syndromes. Annu Rev Physiol 68:123-158
8. Bongianni F, Carla V, Moroni F, Pellegrini-Giampietro DE (1986) Calcium channel inhibitors suppress the morphine-withdrawal syndrome in rats. Br J Pharmacol 88:561-567
9. Candell LM, Yun SH, Tran LL, Ehlert FJ (1990) Differential coupling of subtypes of the muscarinic receptor to adenylate cyclase and phosphoinositide hydrolysis in the longitudinal muscle of the rat ileum. Mol Pharmacol 38:689-697
10. Capasso A, Gallo A (2009) Molecules acting on CB1 receptor and their effects on morphine withdrawal in vitro. Open Biochem J 3:78-84
11. Capasso A, Sorrentino L (1997) Differential influence of D1 and D2 dopamine receptors on acute opiate withdrawal in guinea-pig isolated ileum. Br J Pharmacol 120:1001-1006
12. Carl A, Burtis, Edward R Ashwood (1996) Mineral and bone metabolism. In: Tietz Fundamentals of Clinical Chemistry. W.B. Saunders, Philadelphia, PA, pp 685-703
13. Chen LL, Yu F, Zeng TS, Liao YF, Li YM, Ding HC (2011) Effects of gliclazide on endothelial function in patients with newly diagnosed type 2 diabetes. Eur J Pharmacol 659:296-301
14. Chugh SN, Dhawan R, Kishore K, Sharma A, Chugh K (2001) Glibenclamide vs gliclazide in reducing oxidative stress in patients of noninsulin dependent diabetes mellitus - a double blind randomized study. J Assoc Physicians India 49:803-807
15. Craft S, Foster TC, Landfield PW, Maier SF, Resnick SM, Yaffe K (2012) Session III. Mechanisms of age-related cognitive change and targets for intervention: inflammatory, oxidative, and metabolic processes. J Gerontol A Biol Sci Med Sci 67:754-759
16. ATP signaling pathway. Proc Natl Acad Sci U S A 107:4442-4447
17. Delaey C, Van de Voorde J (1997) Heterogeneity of the inhibitory influence of sulfonylureas on prostanoid-induced smooth muscle contraction. Eur J Pharmacol 325:41-46
18. Drdla R, Gassner M, Gingl E, Sandkühler J (2009) Induction of synaptic long-term potentiation after opioid withdrawal. Science 325:207-210
19. Edwards S, Graham DL, Whisler KN, Self DW (2009) Phosphorylation of GluR1, ERK, and CREB during spontaneous withdrawal from chronic heroin self-administration. Synapse 63:224-235
20. Enquist J, Ferwerda M, Milan-Lobo L, Whistler JL (2012) Chronic methadone treatment shows a better cost/benefit ratio than chronic morphine in mice. J Pharmacol Exp Ther 340:386-392
21. Farahmandfar M, Karimian SM, Zarrindast MR, Kadivar M, Afrouzi H, Naghdi N (2011) Morphine sensitization increases the extracellular level of glutamate in CA1 of rat hippocampus via μ-opioid receptor. Neurosci Lett 494:130-134
22. Ferenczi S, Núñez C, Pintér-Kübler B, Földes A, Martín F, Márkus VL, Milanés MV, Kovács KJ (2010) Changes in metabolic-related variables during chronic morphine treatment. Neurochem Int 57:323-330
23. Griffin MT, Ehlert FJ (1992) Specific inhibition of isoproterenol-stimulated cyclic AMP accumulation by M2 muscarinic receptors in rat intestinal smooth muscle. J Pharmacol Exp Ther 263:221-225
24. Guerrero-Munóz F, Guerrero ML, Way EL (1979) Effect of morphine on calcium uptake by lysed synaptosomes. J Pharmacol Exp Ther 211: 370-374
25. + channel function via the phosphatidylinositol 3-kinase-Akt pathway activated by phenylephrine. J Pharmacol Exp Ther 334:673-678
26. Højsted J, Kurita GP, Kendall S, Lundorff L, de Mattos Pimenta CA, Sjøgren P (2012) Non-analgesic effects of opioids: the cognitive effects of opioids in chronic pain of malignant and non-malignant origin. An update. Curr Pharm Des 18:6116-6122
27. Ipp E, Schusdziarra V, Harris V, Unger RH (1980) Morphine-induced hyperglycemia: role of insulin and glucagon. Endocrinology 107: 461-463
28. Jafari MR, Zarrindast MR, Djahanguiri B (2004) Effects of different doses of glucose and insulin on morphine state-dependent memory of passive avoidance in mice. Psychopharmacology (Berl) 175:457-462
29. 2+ influx. Mol Pharmacol 83:191-205
30. Johansen O, Tønnesen T, Jensen T, Burhol PG, Jorde R, Reikerås O (1993) Morphine and morphine/naloxone modification of glucose, glucagon and insulin levels in fasted and fed rats. Scand J Clin Lab Invest 53:805-809
31. Kaplan M, Aviram M, Hayek T (2012) Oxidative stress and macrophage foam cell formation during diabetes mellitus-induced atherogenesis: role of insulin therapy. Pharmacol Ther 136:175-185
32. Kitamura T, Sato K, Kawamura G, Yamada Y (2012) The involvement of adenosine triphosphate-sensitive potassium channels in the different effects of sevoflurane and propofol on glucose metabolism in fed rats. Anesth Analg 114:110-116
33. Koch T, Seifert A, Wu DF, Rankovic M, Kraus J, Börner C, Brandenburg LO, Schröder H, Höllt V (2009) mu-opioid receptor-stimulated synthesis of reactive oxygen species is mediated via phospholipase D2. J Neurochem 110:1288-1296
34. Kumar N, Dey CS (2002) Gliclazide increases insulin receptor tyrosine phosphorylation but not p38 phosphorylation in insulin-resistant skeletal muscle cells. J Exp Biol 205:3739-3746
35. Lee FA, Baiamonte BA, Spano D, Lahoste GJ, Soignier RD, Harrison LM (2011) Mice lacking rhes show altered morphine analgesia, tolerance, and dependence. Neurosci Lett 489:182-186
36. Li Y, Eitan S, Wu J, Evans CJ, Kieffer B, Sun X, Polakiewicz RD (2003) Morphine induces desensitization of insulin receptor signaling. Mol Cell Biol 23:6255-6266
37. Li H, Liu B, Huang J, Chen H, Guo X, Yuan Z (2013) Insulin inhibits lipopolysaccharide-induced nitric oxide synthase expression in rat primary astrocytes. Brain Res 1506:1-11
38. Liang DY, Li X, Clark JD (2013) Epigenetic regulation of opioid-induced hyperalgesia, dependence, and tolerance in mice. J Pain 14:36-47
39. ATP channel activator diazoxide ameliorates amyloid-β and tau pathologies and improves memory in the 3× TgAD mouse model of Alzheimer's disease. J Alzheimers Dis 22: 443-457
40. Liu L, Coller JK, Watkins LR, Somogyi AA, Hutchinson MR (2011) Naloxone-precipitated morphine withdrawal behavior and brain IL-1β expression: comparison of different mouse strains. Brain Behav Immun 25:1223-1232
41. Mazzucchelli C, Vantaggiato C, Ciamei A, Fasano S, Pakhotin P, Krezel W, Welzl H, Wolfer DP et al(2002) Knockoutof ERK1 MAP kinase enhances synaptic plasticity in the striatum and facilitates striatal-mediated learning and memory. Neuron 34:807-820
42. Mesripour A, Iyer A, Brown L (2012) Mineralocorticoid receptors mediate cardiac remodelling in morphine-dependent rats. Basic Clin Pharmacol Toxicol 111:75-80
43. Moon MJ, Kim HY, Park S, Kim DK, Cho EB, Hwang JI, Seong JY (2011) Insulin contributes to fine-tuning of the pancreatic beta-cell response to glucagon-like peptide-1. Mol Cells 32:389-395
44. Muller DL, Unterwald EM (2004) In vivo regulation of extracellular signal-regulated protein kinase (ERK) and protein kinase B (Akt) phosphorylation by acute and chronic morphine. J Pharmacol Exp Ther 310:774-782
45. Mundey MK, Mason R, Wilson VG (1998) Selective potentiation by ouabain of naloxone-induced withdrawal contractions of isolated guinea-pig ileum following acute exposure to morphine. Br J Pharmacol 124:911-916
46. Ohnota H, Koizumi T, Tsutsumi N, Kobayashi M, Inoue S, Sato F (1994) Novel rapid- and short-acting hypoglycemic agent, a calcium(2 s)-2-benzyl-3-(cis-hexahydro-2-isoindolinylcarbonyl) propionate (KAD-1229) that acts on the sulfonylurea receptor: comparison of effects between KAD-1229 and gliclazide. J Pharmacol Exp Ther 269:489-495
47. Onozato ML, Tojo A, Goto A, Fujita T (2004) Radical scavenging effect of gliclazide in diabetic rats fed with a high cholesterol diet. Kidney Int 65:951-960
48. + channels. Proc West Pharmacol Soc 50:72-74
49. Park SH, Sim YB, Kang YJ, Kim SM, Lee JK, Jung JS, Suh HW (2010) Characterization of blood glucose level regulation in mouse opioid withdrawal models. Neurosci Lett 476:119-122
50. ATP channels in neuroprotective effect of postconditioning in mice. Biol Pharm Bull 31:1755-1760
51. Pfister SL, Pratt PE, Kurian J, Campbell WB (2004) Glibenclamide inhibits thromboxane-mediated vasoconstriction by thromboxane receptor blockade. Vascul Pharmacol 40:285-292
52. Pinelli A, Cighetti G, Trivulzio S (2008) Plasma malondialdehyde levels and opiate withdrawal signs observed in rats treated with morphine plus naloxone: effects of alpha-lipoic acid administration. Fundam Clin Pharmacol 22(4):439-445
53. Pinelli A, Cighetti G, Trivulzio S (2009) Effects of alpha-lipoic acid administration on plasma glucose levels, total malondialdehyde values and withdrawal signs in rats treated with morphine or morphine plus naloxone. Arzneimittelforschung 59:72-78
54. 2+]i elevation induced by arachidonic acid. Biochem Pharmacol 49:1735-1739
55. Radosevich PM, Williams PE, Lacy DB, McRae JR, Steiner KE, Cherrington AD, Lacy WW, Abumrad NN (1984) Effects of morphine on glucose homeostasis in the conscious dog. J Clin Invest 74: 1473-1480
56. Rehni AK, Singh N (2012) Ammonium pyrrolidine dithiocarbamate and RS 102895 attenuate opioid withdrawal in vivo and in vitro. Psychopharmacology (Berl) 220:427-438
57. Rehni AK, Singh N, Rachamalla M, Tikoo K (2012) Modulation of histone deacetylase attenuates naloxone-precipitated opioid withdrawal syndrome. Naunyn Schmiedebergs Arch Pharmacol 385: 605-619
58. 2+ receptor sites after chronic ethanol exposure. Drug Alcohol Depend 2:305-315
59. Saltiel AR, Kahn CR (2001) Insulin signalling and the regulation of glucose and lipid metabolism. Nature 414:799-806
60. Samandari R, Chizari A, Hassanpour R, Mousavi Z, Haghparast A (2013) Streptozotocin-induced diabetes affects the development and maintenance of morphine reward in rats. Neurosci Lett 543:90-94
61. Satyanarayana S, Kilari EK (2006) Influence of nicorandil on the pharmacodynamics and pharmacokinetics of gliclazide in rats and rabbits. Mol Cell Biochem 291:101-105
62. Sharma B, Singh N (2010) Pitavastatin and 4'-hydroxy-3'-methoxyacetophenone (HMAP) reduce cognitive dysfunction in vascular dementia during experimental diabetes. Curr Neurovasc Res 7:180-191
63. Sharma B, Singh N (2011a) Attenuation of vascular dementia by sodium butyrate in streptozotocin diabetic rats. Psychopharmacology (Berl) 215:677-687
64. Sharma B, Singh N (2011b) Behavioral and biochemical investigations to explore pharmacological potential of PPAR-gamma agonists in vascular dementia of diabetic rats. Pharmacol Biochem Behav 100:320-329
65. Sharma B, Singh N (2012a) Salutary effect of NF KB inhibitor and folacin in hyperhomocy steinemia-hyperlipidemia induced vascular dementia. Prog Neuropsychopharmacol Biol Psychiatry 38:207-215
66. Sharma B, Singh N (2012b) Experimental hypertension induced vascular dementia: pharmacological, biochemical and behavioral recuperation by angiotensin receptor blocker and acetylcholinesterase inhibitor. Pharmacol Biochem Behav 102:101-108
67. Sharma B, Singh N (2012c) Defensive effect of natrium diethyldithiocarbamate trihydrate (NDDCT) and lisinopril in DOCA-salt hypertension-induced vascular dementia in rats. Psychopharmacology (Berl) 223:307-317
68. Sharma B, Singh N (2013) Pharmacological inhibition of inducible nitric oxide synthase (iNOS) and nicotinamide adenine dinucleotide phosphate (NADPH) oxidase, convalesce behavior and biochemistry of hypertension induced vascular dementia in rats. Pharmacol Biochem Behav 103:821-830
69. Sharma B, Singh N, Singh M (2008a) Modulation of celecoxib- and streptozotocin-induced experimental dementia of Alzheimer's disease by pitavastatin and donepezil. J Psychopharmacol 22:162-171
70. Sharma B, Singh N, Singh M, Jaggi AS (2008b) Exploitation of HIV protease inhibitor Indinavir as a memory restorative agent in experimental dementia. Pharmacol Biochem Behav 89:535-545
71. + currents through a nitric oxide-cGMP pathway in subthalamic neurons. J Neurosci 30:1882-1893
72. Simpkins JW, Katovich MJ, Millard WJ (1990) Glucose modulation of skin temperature responses during morphine withdrawal in the rat. Psychopharmacology (Berl) 102:213-220
73. Sliwinska A, Rogalska A, Szwed M, Kasznicki J, Jozwiak Z, Drzewoski J (2012) Gliclazide may have an antiapoptotic effect related to its antioxidant properties in human normal and cancer cells. Mol Biol Rep 39:5253-5267
74. Surwit RS, McCubbin JA, Kuhn CM, Cochrane C, Feinglos MN (1989) Differential glycemic effects of morphine in diabetic and normal mice. Metabolism 38:282-285
75. Thomson MJ, Williams MG, Frost SC (1997) Development of insulin resistance in 3 T3-L1 adipocytes. J Biol Chem 272:7759-7764
76. Torres HN, Flawià MM, Hernaez L, Cuatrecasas P (1978) Effects of insulin on the adenylyl cyclase activity of isolated fat cell membranes. J Membr Biol 43:1-18
77. Valeri P, Morrone LA, Romanelli L, Amico MC (1995) Acute withdrawal after bremazocine and the interaction between mu- and kappa-opioid receptors in isolated gut tissues. Br J Pharmacol 114:1206-1210
78. Waxman EA, Lynch DR (2005) N-methyl-D-aspartate receptor subtypes: multiple roles in excitotoxicity and neurological disease. Neuroscientist 11:37-49
79. Way EL, Loh HH, Shen FH (1969) Simultaneous quantitative assessment of morphine tolerance and physical dependence. J Pharmacol Exp Ther 167:1-8
80. Wen T, Peng B, Pintar JE (2009) The MOR-1 opioid receptor regulates glucose homeostasis by modulating insulin secretion. Mol Endocrinol 23:671-678
81. Williams CA, Shih MF, Taberner PV (2000) Effect of acute and sub-chronic administration of the imidazoline compound S 22068 on in vivo glucose and insulin responses in normal lean CBA/Ca mice. Gen Pharmacol 34:183-191
82. Yamamoto H, Harris RA, Loh HH, Way EL (1978) Effects of acute and chronic morphine treatments on calcium localization and binding in brain. J Pharmacol Exp Ther 205:255-264
83. Yang Y, Cheng Y, Lian QQ, Yang L, Qi W, Wu DR, Zheng X, Liu YJ et al (2013) Contribution of CFTR to alveolar fluid clearance by lipoxin A 4 via PI3K/Akt pathway in LPS-induced acute lung injury. Mediators Inflamm 2013:862628
84. Zachariou V, Liu R, LaPlant Q, Xiao G, Renthal W, Chan GC, Storm DR, Aghajanian G, Nestler EJ (2008) Distinct roles of adenylyl cyclases 1 and 8 in opiate dependence: behavioral, electrophysiological, and molecular studies. Biol Psychiatry 63:1013-1021
85. Zhou J, Li Y, Yan G, Bu Q, Lv L, Yang Y, Zhao J, Shao X, Deng Y, Zhu R, Zhao Y, Cen X (2011) Protective role of taurine against morphine-induced neurotoxicity in C6 cells via inhibition of oxidative stress. Neurotox Res 20:334-342